Yes, the Central Drugs Standard Control Organisation (CDSCO) has renamed its Drug Safety Division to Pharmacovigilance and Drug Safety Monitoring (PMDSM) Division. This change highlights CDSCO’s commitment to strengthening drug safety monitoring and pharmacovigilance efforts in India.
The PMDSM Division will focus on:
✅ Detection of adverse drug reactions
✅ Assessment of drug safety concerns
✅ Understanding and preventing drug-related issues
This move aims to enhance the safety and efficacy of pharmaceutical products in the Indian market.
